Author:
Gandomkar Z.,Brennan P. C.,Suleiman M. E.
Publisher
Springer International Publishing
Reference33 articles.
1. WHO Coronavirus Disease (COVID-19) Dashboard. 30th November 2020.
2. Tenford MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network – United States, March–June 2020. Morb Mortal Wkly Rep (MMWR). 2020;69:993–8.
3. Cancer Research UK. Worldwide cancer statistics. 2018. [online] Available at: https://www.cancerresearchuk.org/health-professional/cancerstatistics/worldwide-cancer#:~:text=There%20were%2017%20million%20new,of%20all%20cancers%20diagnosed%20worldwide. [Accessed 15 December 2020].
4. Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, Fry AM, Cannon DL, Chiang CF, Gibbons A, Krapiunaya I. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020;180:1776.
5. Revel MP, Parkar AP, Prosch H, Silva M, Sverzellati N, Gleeson F, Brady A. European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur Radiol. 2020;30(9):4903–4909. https://doi.org/10.1007/s00330-020-06865-y. Epub 2020 Apr 20. PMID: 32314058; PMCID: PMC7170031.